Label: SHISEIDO FUTURE LX TOTAL RADIANCE FOUNDATION E GOLDEN 1- octinoxate cream
SHISEIDO FUTURE LX TOTAL RADIANCE FOUNDATION E GOLDEN 2- octinoxate cream
SHISEIDO FUTURE LX TOTAL RADIANCE FOUNDATION E GOLDEN 3- octinoxate cream
SHISEIDO FUTURE LX TOTAL RADIANCE FOUNDATION E GOLDEN 4- octinoxate cream
SHISEIDO FUTURE LX TOTAL RADIANCE FOUNDATION E NEUTRAL 1- octinoxate cream
SHISEIDO FUTURE LX TOTAL RADIANCE FOUNDATION E NEUTRAL 2- octinoxate cream
SHISEIDO FUTURE LX TOTAL RADIANCE FOUNDATION E NEUTRAL 3- octinoxate cream
SHISEIDO FUTURE LX TOTAL RADIANCE FOUNDATION E NEUTRAL 4- octinoxate cream
SHISEIDO FUTURE LX TOTAL RADIANCE FOUNDATION E ROSE 2- octinoxate cream
SHISEIDO FUTURE LX TOTAL RADIANCE FOUNDATION E ROSE 3- octinoxate cream
SHISEIDO FUTURE LX TOTAL RADIANCE FOUNDATION E ROSE 4- octinoxate cream
-
NDC Code(s):
58411-329-50,
58411-330-50,
58411-331-50,
58411-332-50, view more58411-333-50, 58411-334-50, 58411-335-50, 58411-336-50, 58411-337-50, 58411-338-50, 58411-339-50
- Packager: SHISEIDO AMERICAS CORPORATION
- Category: HUMAN OTC DRUG LABEL
- DEA Schedule: None
Drug Label Information
Updated December 23, 2024
If you are a consumer or patient please visit this version.
- Download DRUG LABEL INFO: PDF XML
- Official Label (Printer Friendly)
- SPL UNCLASSIFIED SECTION
- Active ingredients
- Purpose
-
Uses
- helps prevent sunburn
- if used as directed with other sun protection measures (see Directions), decreases the risk of skin cancer and early skin aging caused by the sun
- Warnings
-
Directions
For sunscreen use:
- apply liberally 15 minutes before sun exposure
- use a water resistant sunscreen if swimming or sweating
- reapply at least every 2 hours
-
Sun Protection Measures. Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease this risk, regularly use a sunscreen with a broad spectrum SPF of 15 or higher and other sun protection measures including:
- limit time in the sun, especially from 10 a.m. – 2 p.m.
- wear long-sleeve shirts, pants, hats, and sunglasses
- children under 6 months: Ask a doctor
-
Inactive Ingredients
WATER∙DIMETHICONE∙GLYCERIN∙NYLON-12∙SD ALCOHOL 40-B∙DIETHYLHEXYL SUCCINATE∙PEG-150∙PEG-9 POLYDIMETHYLSILOXYETHYL DIMETHICONE∙PEG-10 DIMETHICONE∙CYCLOHEXASILOXANE∙SORBITAN SESQUIISOSTEARATE∙POTASSIUM METHOXYSALICYLATE∙TRIMETHYLSILOXYSILICATE∙PIPERIDINEPROPIONIC ACID∙TOCOPHERYL ACETATE∙DIMETHICONE/VINYL DIMETHICONE CROSSPOLYMER∙2-O-ETHYL ASCORBIC ACID∙POLYMETHYL METHACRYLATE∙PRUNUS SPECIOSA LEAF EXTRACT∙ANGELICA ACUTILOBA ROOT EXTRACT∙SODIUM ACETYLATED HYALURONATE∙ISODONIS JAPONICUS LEAF/STALK EXTRACT∙CAMELLIA SINENSIS LEAF EXTRACT∙DISTEARDIMONIUM HECTORITE∙ISODODECANE∙ALUMINUM HYDROXIDE∙DIMETHICONE/PEG-10/15 CROSSPOLYMER∙POLYSILICONE-2∙TRISODIUM EDTA∙BUTYLENE GLYCOL∙SODIUM CITRATE∙BHT∙BARIUM SULFATE∙TOCOPHEROL∙CITRIC ACID∙SODIUM METABISULFITE∙ALCOHOL∙POLYMETHYLSILSESQUIOXANE∙DIPROPYLENE GLYCOL∙ALUMINA∙PHENOXYETHANOL∙FRAGRANCE∙TITANIUM DIOXIDE∙IRON OXIDES∙MICA∙
- Other information
- Questions or comments?
- PRINCIPAL DISPLAY PANEL - 30 mL Jar Carton - Golden 1
- PRINCIPAL DISPLAY PANEL - 30 mL Jar Carton - Golden 2
- PRINCIPAL DISPLAY PANEL - 30 mL Jar Carton - Golden 3
- PRINCIPAL DISPLAY PANEL - 30 mL Jar Carton - Golden 4
- PRINCIPAL DISPLAY PANEL - 30 mL Jar Carton - Neutral 1
- PRINCIPAL DISPLAY PANEL - 30 mL Jar Carton - Neutral 2
- PRINCIPAL DISPLAY PANEL - 30 mL Jar Carton - Neutral 3
- PRINCIPAL DISPLAY PANEL - 30 mL Jar Carton - Neutral 4
- PRINCIPAL DISPLAY PANEL - 30 mL Jar Carton - Rose 2
- PRINCIPAL DISPLAY PANEL - 30 mL Jar Carton - Rose 3
- PRINCIPAL DISPLAY PANEL - 30 mL Jar Carton - Rose 4
-
INGREDIENTS AND APPEARANCE
SHISEIDO FUTURE LX TOTAL RADIANCE FOUNDATION E GOLDEN 1
octinoxate creamProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:58411-329 Route of Administration TOPICAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength OCTINOXATE (UNII: 4Y5P7MUD51) (OCTINOXATE - UNII:4Y5P7MUD51) OCTINOXATE 2036 mg in 30 mL Inactive Ingredients Ingredient Name Strength WATER (UNII: 059QF0KO0R) DIMETHICONE (UNII: 92RU3N3Y1O) GLYCERIN (UNII: PDC6A3C0OX) NYLON-12 (UNII: 446U8J075B) DIETHYLHEXYL SUCCINATE (UNII: 69W9UMG3P8) POLYETHYLENE GLYCOL 7000 (UNII: Q0JET65GEL) PEG-9 POLYDIMETHYLSILOXYETHYL DIMETHICONE (UNII: TYP81E471F) PEG-10 DIMETHICONE (600 CST) (UNII: 8PR7V1SVM0) CYCLOMETHICONE 6 (UNII: XHK3U310BA) POTASSIUM METHOXYSALICYLATE (UNII: 5G3H7U4Y7F) TRIMETHYLSILOXYSILICATE (M/Q 0.6-0.8) (UNII: 5041RX63GN) PIPERIDINEPROPIONIC ACID (UNII: 6L69A7VPHO) .ALPHA.-TOCOPHEROL ACETATE, DL- (UNII: WR1WPI7EW8) DIMETHICONE/VINYL DIMETHICONE CROSSPOLYMER (SOFT PARTICLE) (UNII: 9E4CO0W6C5) 2-O-ETHYL ASCORBIC ACID (UNII: 801M14RK9K) POLY(METHYL METHACRYLATE; 450000 MW) (UNII: Z47NNT4J11) PRUNUS SPECIOSA LEAF (UNII: Q71D900FVU) ANGELICA ACUTILOBA ROOT (UNII: 3W51R3EK30) SODIUM ACETYLATED HYALURONATE (UNII: WN66R7GL93) GREEN TEA LEAF (UNII: W2ZU1RY8B0) DISTEARDIMONIUM HECTORITE (UNII: X687XDK09L) ISODODECANE (UNII: A8289P68Y2) ALUMINUM HYDROXIDE (UNII: 5QB0T2IUN0) EDETATE TRISODIUM (UNII: 420IP921MB) BUTYLENE GLYCOL (UNII: 3XUS85K0RA) SODIUM CITRATE, UNSPECIFIED FORM (UNII: 1Q73Q2JULR) BUTYLATED HYDROXYTOLUENE (UNII: 1P9D0Z171K) BARIUM SULFATE (UNII: 25BB7EKE2E) .ALPHA.-TOCOPHEROL (UNII: H4N855PNZ1) CITRIC ACID MONOHYDRATE (UNII: 2968PHW8QP) SODIUM METABISULFITE (UNII: 4VON5FNS3C) ALCOHOL (UNII: 3K9958V90M) POLYMETHYLSILSESQUIOXANE (4.5 MICRONS) (UNII: 59Z907ZB69) DIPROPYLENE GLYCOL (UNII: E107L85C40) ALUMINUM OXIDE (UNII: LMI26O6933) PHENOXYETHANOL (UNII: HIE492ZZ3T) TITANIUM DIOXIDE (UNII: 15FIX9V2JP) FERRIC OXIDE RED (UNII: 1K09F3G675) FERRIC OXIDE YELLOW (UNII: EX438O2MRT) FERROSOFERRIC OXIDE (UNII: XM0M87F357) MICA (UNII: V8A1AW0880) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:58411-329-50 1 in 1 CARTON 08/01/2017 1 30 mL in 1 JAR; Type 0: Not a Combination Product Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC MONOGRAPH DRUG M020 08/01/2017 SHISEIDO FUTURE LX TOTAL RADIANCE FOUNDATION E GOLDEN 2
octinoxate creamProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:58411-330 Route of Administration TOPICAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength OCTINOXATE (UNII: 4Y5P7MUD51) (OCTINOXATE - UNII:4Y5P7MUD51) OCTINOXATE 1832 mg in 30 mL Inactive Ingredients Ingredient Name Strength WATER (UNII: 059QF0KO0R) DIMETHICONE (UNII: 92RU3N3Y1O) GLYCERIN (UNII: PDC6A3C0OX) NYLON-12 (UNII: 446U8J075B) DIETHYLHEXYL SUCCINATE (UNII: 69W9UMG3P8) POLYETHYLENE GLYCOL 7000 (UNII: Q0JET65GEL) PEG-9 POLYDIMETHYLSILOXYETHYL DIMETHICONE (UNII: TYP81E471F) PEG-10 DIMETHICONE (600 CST) (UNII: 8PR7V1SVM0) CYCLOMETHICONE 6 (UNII: XHK3U310BA) POTASSIUM METHOXYSALICYLATE (UNII: 5G3H7U4Y7F) TRIMETHYLSILOXYSILICATE (M/Q 0.6-0.8) (UNII: 5041RX63GN) PIPERIDINEPROPIONIC ACID (UNII: 6L69A7VPHO) .ALPHA.-TOCOPHEROL ACETATE, DL- (UNII: WR1WPI7EW8) DIMETHICONE/VINYL DIMETHICONE CROSSPOLYMER (SOFT PARTICLE) (UNII: 9E4CO0W6C5) 2-O-ETHYL ASCORBIC ACID (UNII: 801M14RK9K) POLY(METHYL METHACRYLATE; 450000 MW) (UNII: Z47NNT4J11) PRUNUS SPECIOSA LEAF (UNII: Q71D900FVU) ANGELICA ACUTILOBA ROOT (UNII: 3W51R3EK30) SODIUM ACETYLATED HYALURONATE (UNII: WN66R7GL93) GREEN TEA LEAF (UNII: W2ZU1RY8B0) DISTEARDIMONIUM HECTORITE (UNII: X687XDK09L) ISODODECANE (UNII: A8289P68Y2) ALUMINUM HYDROXIDE (UNII: 5QB0T2IUN0) EDETATE TRISODIUM (UNII: 420IP921MB) BUTYLENE GLYCOL (UNII: 3XUS85K0RA) SODIUM CITRATE, UNSPECIFIED FORM (UNII: 1Q73Q2JULR) BUTYLATED HYDROXYTOLUENE (UNII: 1P9D0Z171K) BARIUM SULFATE (UNII: 25BB7EKE2E) .ALPHA.-TOCOPHEROL (UNII: H4N855PNZ1) CITRIC ACID MONOHYDRATE (UNII: 2968PHW8QP) SODIUM METABISULFITE (UNII: 4VON5FNS3C) ALCOHOL (UNII: 3K9958V90M) POLYMETHYLSILSESQUIOXANE (4.5 MICRONS) (UNII: 59Z907ZB69) DIPROPYLENE GLYCOL (UNII: E107L85C40) ALUMINUM OXIDE (UNII: LMI26O6933) PHENOXYETHANOL (UNII: HIE492ZZ3T) TITANIUM DIOXIDE (UNII: 15FIX9V2JP) FERRIC OXIDE RED (UNII: 1K09F3G675) FERRIC OXIDE YELLOW (UNII: EX438O2MRT) FERROSOFERRIC OXIDE (UNII: XM0M87F357) MICA (UNII: V8A1AW0880) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:58411-330-50 1 in 1 CARTON 08/01/2017 1 30 mL in 1 JAR; Type 0: Not a Combination Product Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC MONOGRAPH DRUG M020 08/01/2017 SHISEIDO FUTURE LX TOTAL RADIANCE FOUNDATION E GOLDEN 3
octinoxate creamProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:58411-331 Route of Administration TOPICAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength OCTINOXATE (UNII: 4Y5P7MUD51) (OCTINOXATE - UNII:4Y5P7MUD51) OCTINOXATE 1832 mg in 30 mL Inactive Ingredients Ingredient Name Strength WATER (UNII: 059QF0KO0R) DIMETHICONE (UNII: 92RU3N3Y1O) GLYCERIN (UNII: PDC6A3C0OX) NYLON-12 (UNII: 446U8J075B) DIETHYLHEXYL SUCCINATE (UNII: 69W9UMG3P8) POLYETHYLENE GLYCOL 7000 (UNII: Q0JET65GEL) PEG-9 POLYDIMETHYLSILOXYETHYL DIMETHICONE (UNII: TYP81E471F) PEG-10 DIMETHICONE (600 CST) (UNII: 8PR7V1SVM0) CYCLOMETHICONE 6 (UNII: XHK3U310BA) POTASSIUM METHOXYSALICYLATE (UNII: 5G3H7U4Y7F) TRIMETHYLSILOXYSILICATE (M/Q 0.6-0.8) (UNII: 5041RX63GN) PIPERIDINEPROPIONIC ACID (UNII: 6L69A7VPHO) .ALPHA.-TOCOPHEROL ACETATE, DL- (UNII: WR1WPI7EW8) DIMETHICONE/VINYL DIMETHICONE CROSSPOLYMER (SOFT PARTICLE) (UNII: 9E4CO0W6C5) 2-O-ETHYL ASCORBIC ACID (UNII: 801M14RK9K) POLY(METHYL METHACRYLATE; 450000 MW) (UNII: Z47NNT4J11) PRUNUS SPECIOSA LEAF (UNII: Q71D900FVU) ANGELICA ACUTILOBA ROOT (UNII: 3W51R3EK30) SODIUM ACETYLATED HYALURONATE (UNII: WN66R7GL93) GREEN TEA LEAF (UNII: W2ZU1RY8B0) DISTEARDIMONIUM HECTORITE (UNII: X687XDK09L) ISODODECANE (UNII: A8289P68Y2) ALUMINUM HYDROXIDE (UNII: 5QB0T2IUN0) EDETATE TRISODIUM (UNII: 420IP921MB) BUTYLENE GLYCOL (UNII: 3XUS85K0RA) SODIUM CITRATE, UNSPECIFIED FORM (UNII: 1Q73Q2JULR) BUTYLATED HYDROXYTOLUENE (UNII: 1P9D0Z171K) BARIUM SULFATE (UNII: 25BB7EKE2E) .ALPHA.-TOCOPHEROL (UNII: H4N855PNZ1) CITRIC ACID MONOHYDRATE (UNII: 2968PHW8QP) SODIUM METABISULFITE (UNII: 4VON5FNS3C) ALCOHOL (UNII: 3K9958V90M) POLYMETHYLSILSESQUIOXANE (4.5 MICRONS) (UNII: 59Z907ZB69) DIPROPYLENE GLYCOL (UNII: E107L85C40) ALUMINUM OXIDE (UNII: LMI26O6933) PHENOXYETHANOL (UNII: HIE492ZZ3T) TITANIUM DIOXIDE (UNII: 15FIX9V2JP) FERRIC OXIDE RED (UNII: 1K09F3G675) FERRIC OXIDE YELLOW (UNII: EX438O2MRT) FERROSOFERRIC OXIDE (UNII: XM0M87F357) MICA (UNII: V8A1AW0880) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:58411-331-50 1 in 1 CARTON 08/01/2017 1 30 mL in 1 JAR; Type 0: Not a Combination Product Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC MONOGRAPH DRUG M020 08/01/2017 SHISEIDO FUTURE LX TOTAL RADIANCE FOUNDATION E GOLDEN 4
octinoxate creamProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:58411-332 Route of Administration TOPICAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength OCTINOXATE (UNII: 4Y5P7MUD51) (OCTINOXATE - UNII:4Y5P7MUD51) OCTINOXATE 1832 mg in 30 mL Inactive Ingredients Ingredient Name Strength WATER (UNII: 059QF0KO0R) DIMETHICONE (UNII: 92RU3N3Y1O) GLYCERIN (UNII: PDC6A3C0OX) NYLON-12 (UNII: 446U8J075B) DIETHYLHEXYL SUCCINATE (UNII: 69W9UMG3P8) POLYETHYLENE GLYCOL 7000 (UNII: Q0JET65GEL) PEG-9 POLYDIMETHYLSILOXYETHYL DIMETHICONE (UNII: TYP81E471F) PEG-10 DIMETHICONE (600 CST) (UNII: 8PR7V1SVM0) CYCLOMETHICONE 6 (UNII: XHK3U310BA) POTASSIUM METHOXYSALICYLATE (UNII: 5G3H7U4Y7F) TRIMETHYLSILOXYSILICATE (M/Q 0.6-0.8) (UNII: 5041RX63GN) PIPERIDINEPROPIONIC ACID (UNII: 6L69A7VPHO) .ALPHA.-TOCOPHEROL ACETATE, DL- (UNII: WR1WPI7EW8) DIMETHICONE/VINYL DIMETHICONE CROSSPOLYMER (SOFT PARTICLE) (UNII: 9E4CO0W6C5) 2-O-ETHYL ASCORBIC ACID (UNII: 801M14RK9K) POLY(METHYL METHACRYLATE; 450000 MW) (UNII: Z47NNT4J11) PRUNUS SPECIOSA LEAF (UNII: Q71D900FVU) ANGELICA ACUTILOBA ROOT (UNII: 3W51R3EK30) SODIUM ACETYLATED HYALURONATE (UNII: WN66R7GL93) GREEN TEA LEAF (UNII: W2ZU1RY8B0) DISTEARDIMONIUM HECTORITE (UNII: X687XDK09L) ISODODECANE (UNII: A8289P68Y2) ALUMINUM HYDROXIDE (UNII: 5QB0T2IUN0) EDETATE TRISODIUM (UNII: 420IP921MB) BUTYLENE GLYCOL (UNII: 3XUS85K0RA) SODIUM CITRATE, UNSPECIFIED FORM (UNII: 1Q73Q2JULR) BUTYLATED HYDROXYTOLUENE (UNII: 1P9D0Z171K) BARIUM SULFATE (UNII: 25BB7EKE2E) .ALPHA.-TOCOPHEROL (UNII: H4N855PNZ1) CITRIC ACID MONOHYDRATE (UNII: 2968PHW8QP) SODIUM METABISULFITE (UNII: 4VON5FNS3C) ALCOHOL (UNII: 3K9958V90M) POLYMETHYLSILSESQUIOXANE (4.5 MICRONS) (UNII: 59Z907ZB69) DIPROPYLENE GLYCOL (UNII: E107L85C40) ALUMINUM OXIDE (UNII: LMI26O6933) PHENOXYETHANOL (UNII: HIE492ZZ3T) TITANIUM DIOXIDE (UNII: 15FIX9V2JP) FERRIC OXIDE RED (UNII: 1K09F3G675) FERRIC OXIDE YELLOW (UNII: EX438O2MRT) FERROSOFERRIC OXIDE (UNII: XM0M87F357) MICA (UNII: V8A1AW0880) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:58411-332-50 1 in 1 CARTON 08/01/2017 1 30 mL in 1 JAR; Type 0: Not a Combination Product Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC MONOGRAPH DRUG M020 08/01/2017 SHISEIDO FUTURE LX TOTAL RADIANCE FOUNDATION E NEUTRAL 1
octinoxate creamProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:58411-333 Route of Administration TOPICAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength OCTINOXATE (UNII: 4Y5P7MUD51) (OCTINOXATE - UNII:4Y5P7MUD51) OCTINOXATE 1832 mg in 30 mL Inactive Ingredients Ingredient Name Strength WATER (UNII: 059QF0KO0R) DIMETHICONE (UNII: 92RU3N3Y1O) GLYCERIN (UNII: PDC6A3C0OX) NYLON-12 (UNII: 446U8J075B) DIETHYLHEXYL SUCCINATE (UNII: 69W9UMG3P8) POLYETHYLENE GLYCOL 7000 (UNII: Q0JET65GEL) PEG-9 POLYDIMETHYLSILOXYETHYL DIMETHICONE (UNII: TYP81E471F) PEG-10 DIMETHICONE (600 CST) (UNII: 8PR7V1SVM0) CYCLOMETHICONE 6 (UNII: XHK3U310BA) POTASSIUM METHOXYSALICYLATE (UNII: 5G3H7U4Y7F) TRIMETHYLSILOXYSILICATE (M/Q 0.6-0.8) (UNII: 5041RX63GN) PIPERIDINEPROPIONIC ACID (UNII: 6L69A7VPHO) .ALPHA.-TOCOPHEROL ACETATE, DL- (UNII: WR1WPI7EW8) DIMETHICONE/VINYL DIMETHICONE CROSSPOLYMER (SOFT PARTICLE) (UNII: 9E4CO0W6C5) 2-O-ETHYL ASCORBIC ACID (UNII: 801M14RK9K) POLY(METHYL METHACRYLATE; 450000 MW) (UNII: Z47NNT4J11) PRUNUS SPECIOSA LEAF (UNII: Q71D900FVU) ANGELICA ACUTILOBA ROOT (UNII: 3W51R3EK30) SODIUM ACETYLATED HYALURONATE (UNII: WN66R7GL93) GREEN TEA LEAF (UNII: W2ZU1RY8B0) DISTEARDIMONIUM HECTORITE (UNII: X687XDK09L) ISODODECANE (UNII: A8289P68Y2) ALUMINUM HYDROXIDE (UNII: 5QB0T2IUN0) EDETATE TRISODIUM (UNII: 420IP921MB) BUTYLENE GLYCOL (UNII: 3XUS85K0RA) SODIUM CITRATE, UNSPECIFIED FORM (UNII: 1Q73Q2JULR) BUTYLATED HYDROXYTOLUENE (UNII: 1P9D0Z171K) BARIUM SULFATE (UNII: 25BB7EKE2E) .ALPHA.-TOCOPHEROL (UNII: H4N855PNZ1) CITRIC ACID MONOHYDRATE (UNII: 2968PHW8QP) SODIUM METABISULFITE (UNII: 4VON5FNS3C) ALCOHOL (UNII: 3K9958V90M) POLYMETHYLSILSESQUIOXANE (4.5 MICRONS) (UNII: 59Z907ZB69) DIPROPYLENE GLYCOL (UNII: E107L85C40) ALUMINUM OXIDE (UNII: LMI26O6933) PHENOXYETHANOL (UNII: HIE492ZZ3T) TITANIUM DIOXIDE (UNII: 15FIX9V2JP) FERRIC OXIDE RED (UNII: 1K09F3G675) FERRIC OXIDE YELLOW (UNII: EX438O2MRT) FERROSOFERRIC OXIDE (UNII: XM0M87F357) MICA (UNII: V8A1AW0880) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:58411-333-50 1 in 1 CARTON 08/01/2017 1 30 mL in 1 JAR; Type 0: Not a Combination Product Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC MONOGRAPH DRUG M020 08/01/2017 SHISEIDO FUTURE LX TOTAL RADIANCE FOUNDATION E NEUTRAL 2
octinoxate creamProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:58411-334 Route of Administration TOPICAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength OCTINOXATE (UNII: 4Y5P7MUD51) (OCTINOXATE - UNII:4Y5P7MUD51) OCTINOXATE 1832 mg in 30 mL Inactive Ingredients Ingredient Name Strength WATER (UNII: 059QF0KO0R) DIMETHICONE (UNII: 92RU3N3Y1O) GLYCERIN (UNII: PDC6A3C0OX) NYLON-12 (UNII: 446U8J075B) DIETHYLHEXYL SUCCINATE (UNII: 69W9UMG3P8) POLYETHYLENE GLYCOL 7000 (UNII: Q0JET65GEL) PEG-9 POLYDIMETHYLSILOXYETHYL DIMETHICONE (UNII: TYP81E471F) PEG-10 DIMETHICONE (600 CST) (UNII: 8PR7V1SVM0) CYCLOMETHICONE 6 (UNII: XHK3U310BA) POTASSIUM METHOXYSALICYLATE (UNII: 5G3H7U4Y7F) TRIMETHYLSILOXYSILICATE (M/Q 0.6-0.8) (UNII: 5041RX63GN) PIPERIDINEPROPIONIC ACID (UNII: 6L69A7VPHO) .ALPHA.-TOCOPHEROL ACETATE, DL- (UNII: WR1WPI7EW8) DIMETHICONE/VINYL DIMETHICONE CROSSPOLYMER (SOFT PARTICLE) (UNII: 9E4CO0W6C5) 2-O-ETHYL ASCORBIC ACID (UNII: 801M14RK9K) POLY(METHYL METHACRYLATE; 450000 MW) (UNII: Z47NNT4J11) PRUNUS SPECIOSA LEAF (UNII: Q71D900FVU) ANGELICA ACUTILOBA ROOT (UNII: 3W51R3EK30) SODIUM ACETYLATED HYALURONATE (UNII: WN66R7GL93) GREEN TEA LEAF (UNII: W2ZU1RY8B0) DISTEARDIMONIUM HECTORITE (UNII: X687XDK09L) ISODODECANE (UNII: A8289P68Y2) ALUMINUM HYDROXIDE (UNII: 5QB0T2IUN0) EDETATE TRISODIUM (UNII: 420IP921MB) BUTYLENE GLYCOL (UNII: 3XUS85K0RA) SODIUM CITRATE, UNSPECIFIED FORM (UNII: 1Q73Q2JULR) BUTYLATED HYDROXYTOLUENE (UNII: 1P9D0Z171K) BARIUM SULFATE (UNII: 25BB7EKE2E) .ALPHA.-TOCOPHEROL (UNII: H4N855PNZ1) CITRIC ACID MONOHYDRATE (UNII: 2968PHW8QP) SODIUM METABISULFITE (UNII: 4VON5FNS3C) ALCOHOL (UNII: 3K9958V90M) POLYMETHYLSILSESQUIOXANE (4.5 MICRONS) (UNII: 59Z907ZB69) DIPROPYLENE GLYCOL (UNII: E107L85C40) ALUMINUM OXIDE (UNII: LMI26O6933) PHENOXYETHANOL (UNII: HIE492ZZ3T) TITANIUM DIOXIDE (UNII: 15FIX9V2JP) FERRIC OXIDE RED (UNII: 1K09F3G675) FERRIC OXIDE YELLOW (UNII: EX438O2MRT) FERROSOFERRIC OXIDE (UNII: XM0M87F357) MICA (UNII: V8A1AW0880) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:58411-334-50 1 in 1 CARTON 08/01/2017 1 30 mL in 1 JAR; Type 0: Not a Combination Product Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC MONOGRAPH DRUG M020 08/01/2017 SHISEIDO FUTURE LX TOTAL RADIANCE FOUNDATION E NEUTRAL 3
octinoxate creamProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:58411-335 Route of Administration TOPICAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength OCTINOXATE (UNII: 4Y5P7MUD51) (OCTINOXATE - UNII:4Y5P7MUD51) OCTINOXATE 1832 mg in 30 mL Inactive Ingredients Ingredient Name Strength WATER (UNII: 059QF0KO0R) DIMETHICONE (UNII: 92RU3N3Y1O) GLYCERIN (UNII: PDC6A3C0OX) NYLON-12 (UNII: 446U8J075B) DIETHYLHEXYL SUCCINATE (UNII: 69W9UMG3P8) POLYETHYLENE GLYCOL 7000 (UNII: Q0JET65GEL) PEG-9 POLYDIMETHYLSILOXYETHYL DIMETHICONE (UNII: TYP81E471F) PEG-10 DIMETHICONE (600 CST) (UNII: 8PR7V1SVM0) CYCLOMETHICONE 6 (UNII: XHK3U310BA) POTASSIUM METHOXYSALICYLATE (UNII: 5G3H7U4Y7F) TRIMETHYLSILOXYSILICATE (M/Q 0.6-0.8) (UNII: 5041RX63GN) PIPERIDINEPROPIONIC ACID (UNII: 6L69A7VPHO) .ALPHA.-TOCOPHEROL ACETATE, DL- (UNII: WR1WPI7EW8) DIMETHICONE/VINYL DIMETHICONE CROSSPOLYMER (SOFT PARTICLE) (UNII: 9E4CO0W6C5) 2-O-ETHYL ASCORBIC ACID (UNII: 801M14RK9K) POLY(METHYL METHACRYLATE; 450000 MW) (UNII: Z47NNT4J11) PRUNUS SPECIOSA LEAF (UNII: Q71D900FVU) ANGELICA ACUTILOBA ROOT (UNII: 3W51R3EK30) SODIUM ACETYLATED HYALURONATE (UNII: WN66R7GL93) GREEN TEA LEAF (UNII: W2ZU1RY8B0) DISTEARDIMONIUM HECTORITE (UNII: X687XDK09L) ISODODECANE (UNII: A8289P68Y2) ALUMINUM HYDROXIDE (UNII: 5QB0T2IUN0) EDETATE TRISODIUM (UNII: 420IP921MB) BUTYLENE GLYCOL (UNII: 3XUS85K0RA) SODIUM CITRATE, UNSPECIFIED FORM (UNII: 1Q73Q2JULR) BUTYLATED HYDROXYTOLUENE (UNII: 1P9D0Z171K) BARIUM SULFATE (UNII: 25BB7EKE2E) .ALPHA.-TOCOPHEROL (UNII: H4N855PNZ1) CITRIC ACID MONOHYDRATE (UNII: 2968PHW8QP) SODIUM METABISULFITE (UNII: 4VON5FNS3C) ALCOHOL (UNII: 3K9958V90M) POLYMETHYLSILSESQUIOXANE (4.5 MICRONS) (UNII: 59Z907ZB69) DIPROPYLENE GLYCOL (UNII: E107L85C40) ALUMINUM OXIDE (UNII: LMI26O6933) PHENOXYETHANOL (UNII: HIE492ZZ3T) TITANIUM DIOXIDE (UNII: 15FIX9V2JP) FERRIC OXIDE RED (UNII: 1K09F3G675) FERRIC OXIDE YELLOW (UNII: EX438O2MRT) FERROSOFERRIC OXIDE (UNII: XM0M87F357) MICA (UNII: V8A1AW0880) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:58411-335-50 1 in 1 CARTON 08/01/2017 1 30 mL in 1 JAR; Type 0: Not a Combination Product Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC MONOGRAPH DRUG M020 08/01/2017 SHISEIDO FUTURE LX TOTAL RADIANCE FOUNDATION E NEUTRAL 4
octinoxate creamProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:58411-336 Route of Administration TOPICAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength OCTINOXATE (UNII: 4Y5P7MUD51) (OCTINOXATE - UNII:4Y5P7MUD51) OCTINOXATE 1832 mg in 30 mL Inactive Ingredients Ingredient Name Strength WATER (UNII: 059QF0KO0R) DIMETHICONE (UNII: 92RU3N3Y1O) GLYCERIN (UNII: PDC6A3C0OX) NYLON-12 (UNII: 446U8J075B) DIETHYLHEXYL SUCCINATE (UNII: 69W9UMG3P8) POLYETHYLENE GLYCOL 7000 (UNII: Q0JET65GEL) PEG-9 POLYDIMETHYLSILOXYETHYL DIMETHICONE (UNII: TYP81E471F) PEG-10 DIMETHICONE (600 CST) (UNII: 8PR7V1SVM0) CYCLOMETHICONE 6 (UNII: XHK3U310BA) POTASSIUM METHOXYSALICYLATE (UNII: 5G3H7U4Y7F) TRIMETHYLSILOXYSILICATE (M/Q 0.6-0.8) (UNII: 5041RX63GN) PIPERIDINEPROPIONIC ACID (UNII: 6L69A7VPHO) .ALPHA.-TOCOPHEROL ACETATE, DL- (UNII: WR1WPI7EW8) DIMETHICONE/VINYL DIMETHICONE CROSSPOLYMER (SOFT PARTICLE) (UNII: 9E4CO0W6C5) 2-O-ETHYL ASCORBIC ACID (UNII: 801M14RK9K) POLY(METHYL METHACRYLATE; 450000 MW) (UNII: Z47NNT4J11) PRUNUS SPECIOSA LEAF (UNII: Q71D900FVU) ANGELICA ACUTILOBA ROOT (UNII: 3W51R3EK30) SODIUM ACETYLATED HYALURONATE (UNII: WN66R7GL93) GREEN TEA LEAF (UNII: W2ZU1RY8B0) DISTEARDIMONIUM HECTORITE (UNII: X687XDK09L) ISODODECANE (UNII: A8289P68Y2) ALUMINUM HYDROXIDE (UNII: 5QB0T2IUN0) EDETATE TRISODIUM (UNII: 420IP921MB) BUTYLENE GLYCOL (UNII: 3XUS85K0RA) SODIUM CITRATE, UNSPECIFIED FORM (UNII: 1Q73Q2JULR) BUTYLATED HYDROXYTOLUENE (UNII: 1P9D0Z171K) BARIUM SULFATE (UNII: 25BB7EKE2E) .ALPHA.-TOCOPHEROL (UNII: H4N855PNZ1) CITRIC ACID MONOHYDRATE (UNII: 2968PHW8QP) SODIUM METABISULFITE (UNII: 4VON5FNS3C) ALCOHOL (UNII: 3K9958V90M) POLYMETHYLSILSESQUIOXANE (4.5 MICRONS) (UNII: 59Z907ZB69) DIPROPYLENE GLYCOL (UNII: E107L85C40) ALUMINUM OXIDE (UNII: LMI26O6933) PHENOXYETHANOL (UNII: HIE492ZZ3T) TITANIUM DIOXIDE (UNII: 15FIX9V2JP) FERRIC OXIDE RED (UNII: 1K09F3G675) FERRIC OXIDE YELLOW (UNII: EX438O2MRT) FERROSOFERRIC OXIDE (UNII: XM0M87F357) MICA (UNII: V8A1AW0880) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:58411-336-50 1 in 1 CARTON 08/01/2017 1 30 mL in 1 JAR; Type 0: Not a Combination Product Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC MONOGRAPH DRUG M020 08/01/2017 SHISEIDO FUTURE LX TOTAL RADIANCE FOUNDATION E ROSE 2
octinoxate creamProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:58411-337 Route of Administration TOPICAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength OCTINOXATE (UNII: 4Y5P7MUD51) (OCTINOXATE - UNII:4Y5P7MUD51) OCTINOXATE 1832 mg in 30 mL Inactive Ingredients Ingredient Name Strength WATER (UNII: 059QF0KO0R) DIMETHICONE (UNII: 92RU3N3Y1O) GLYCERIN (UNII: PDC6A3C0OX) NYLON-12 (UNII: 446U8J075B) DIETHYLHEXYL SUCCINATE (UNII: 69W9UMG3P8) POLYETHYLENE GLYCOL 7000 (UNII: Q0JET65GEL) PEG-9 POLYDIMETHYLSILOXYETHYL DIMETHICONE (UNII: TYP81E471F) PEG-10 DIMETHICONE (600 CST) (UNII: 8PR7V1SVM0) CYCLOMETHICONE 6 (UNII: XHK3U310BA) POTASSIUM METHOXYSALICYLATE (UNII: 5G3H7U4Y7F) TRIMETHYLSILOXYSILICATE (M/Q 0.6-0.8) (UNII: 5041RX63GN) PIPERIDINEPROPIONIC ACID (UNII: 6L69A7VPHO) .ALPHA.-TOCOPHEROL ACETATE, DL- (UNII: WR1WPI7EW8) DIMETHICONE/VINYL DIMETHICONE CROSSPOLYMER (SOFT PARTICLE) (UNII: 9E4CO0W6C5) 2-O-ETHYL ASCORBIC ACID (UNII: 801M14RK9K) POLY(METHYL METHACRYLATE; 450000 MW) (UNII: Z47NNT4J11) PRUNUS SPECIOSA LEAF (UNII: Q71D900FVU) ANGELICA ACUTILOBA ROOT (UNII: 3W51R3EK30) SODIUM ACETYLATED HYALURONATE (UNII: WN66R7GL93) GREEN TEA LEAF (UNII: W2ZU1RY8B0) DISTEARDIMONIUM HECTORITE (UNII: X687XDK09L) ISODODECANE (UNII: A8289P68Y2) ALUMINUM HYDROXIDE (UNII: 5QB0T2IUN0) EDETATE TRISODIUM (UNII: 420IP921MB) BUTYLENE GLYCOL (UNII: 3XUS85K0RA) SODIUM CITRATE, UNSPECIFIED FORM (UNII: 1Q73Q2JULR) BUTYLATED HYDROXYTOLUENE (UNII: 1P9D0Z171K) BARIUM SULFATE (UNII: 25BB7EKE2E) .ALPHA.-TOCOPHEROL (UNII: H4N855PNZ1) CITRIC ACID MONOHYDRATE (UNII: 2968PHW8QP) SODIUM METABISULFITE (UNII: 4VON5FNS3C) ALCOHOL (UNII: 3K9958V90M) POLYMETHYLSILSESQUIOXANE (4.5 MICRONS) (UNII: 59Z907ZB69) DIPROPYLENE GLYCOL (UNII: E107L85C40) ALUMINUM OXIDE (UNII: LMI26O6933) PHENOXYETHANOL (UNII: HIE492ZZ3T) TITANIUM DIOXIDE (UNII: 15FIX9V2JP) FERRIC OXIDE RED (UNII: 1K09F3G675) FERRIC OXIDE YELLOW (UNII: EX438O2MRT) FERROSOFERRIC OXIDE (UNII: XM0M87F357) MICA (UNII: V8A1AW0880) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:58411-337-50 1 in 1 CARTON 08/01/2017 1 30 mL in 1 JAR; Type 0: Not a Combination Product Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC MONOGRAPH DRUG M020 08/01/2017 SHISEIDO FUTURE LX TOTAL RADIANCE FOUNDATION E ROSE 3
octinoxate creamProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:58411-338 Route of Administration TOPICAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength OCTINOXATE (UNII: 4Y5P7MUD51) (OCTINOXATE - UNII:4Y5P7MUD51) OCTINOXATE 1832 mg in 30 mL Inactive Ingredients Ingredient Name Strength WATER (UNII: 059QF0KO0R) DIMETHICONE (UNII: 92RU3N3Y1O) GLYCERIN (UNII: PDC6A3C0OX) NYLON-12 (UNII: 446U8J075B) DIETHYLHEXYL SUCCINATE (UNII: 69W9UMG3P8) POLYETHYLENE GLYCOL 7000 (UNII: Q0JET65GEL) PEG-9 POLYDIMETHYLSILOXYETHYL DIMETHICONE (UNII: TYP81E471F) PEG-10 DIMETHICONE (600 CST) (UNII: 8PR7V1SVM0) CYCLOMETHICONE 6 (UNII: XHK3U310BA) POTASSIUM METHOXYSALICYLATE (UNII: 5G3H7U4Y7F) TRIMETHYLSILOXYSILICATE (M/Q 0.6-0.8) (UNII: 5041RX63GN) PIPERIDINEPROPIONIC ACID (UNII: 6L69A7VPHO) .ALPHA.-TOCOPHEROL ACETATE, DL- (UNII: WR1WPI7EW8) DIMETHICONE/VINYL DIMETHICONE CROSSPOLYMER (SOFT PARTICLE) (UNII: 9E4CO0W6C5) 2-O-ETHYL ASCORBIC ACID (UNII: 801M14RK9K) POLY(METHYL METHACRYLATE; 450000 MW) (UNII: Z47NNT4J11) PRUNUS SPECIOSA LEAF (UNII: Q71D900FVU) ANGELICA ACUTILOBA ROOT (UNII: 3W51R3EK30) SODIUM ACETYLATED HYALURONATE (UNII: WN66R7GL93) GREEN TEA LEAF (UNII: W2ZU1RY8B0) DISTEARDIMONIUM HECTORITE (UNII: X687XDK09L) ISODODECANE (UNII: A8289P68Y2) ALUMINUM HYDROXIDE (UNII: 5QB0T2IUN0) EDETATE TRISODIUM (UNII: 420IP921MB) BUTYLENE GLYCOL (UNII: 3XUS85K0RA) SODIUM CITRATE, UNSPECIFIED FORM (UNII: 1Q73Q2JULR) BUTYLATED HYDROXYTOLUENE (UNII: 1P9D0Z171K) BARIUM SULFATE (UNII: 25BB7EKE2E) .ALPHA.-TOCOPHEROL (UNII: H4N855PNZ1) CITRIC ACID MONOHYDRATE (UNII: 2968PHW8QP) SODIUM METABISULFITE (UNII: 4VON5FNS3C) ALCOHOL (UNII: 3K9958V90M) POLYMETHYLSILSESQUIOXANE (4.5 MICRONS) (UNII: 59Z907ZB69) DIPROPYLENE GLYCOL (UNII: E107L85C40) ALUMINUM OXIDE (UNII: LMI26O6933) PHENOXYETHANOL (UNII: HIE492ZZ3T) TITANIUM DIOXIDE (UNII: 15FIX9V2JP) FERRIC OXIDE RED (UNII: 1K09F3G675) FERRIC OXIDE YELLOW (UNII: EX438O2MRT) FERROSOFERRIC OXIDE (UNII: XM0M87F357) MICA (UNII: V8A1AW0880) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:58411-338-50 1 in 1 CARTON 08/01/2017 1 30 mL in 1 JAR; Type 0: Not a Combination Product Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC MONOGRAPH DRUG M020 08/01/2017 SHISEIDO FUTURE LX TOTAL RADIANCE FOUNDATION E ROSE 4
octinoxate creamProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:58411-339 Route of Administration TOPICAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength OCTINOXATE (UNII: 4Y5P7MUD51) (OCTINOXATE - UNII:4Y5P7MUD51) OCTINOXATE 1832 mg in 30 mL Inactive Ingredients Ingredient Name Strength WATER (UNII: 059QF0KO0R) DIMETHICONE (UNII: 92RU3N3Y1O) GLYCERIN (UNII: PDC6A3C0OX) NYLON-12 (UNII: 446U8J075B) DIETHYLHEXYL SUCCINATE (UNII: 69W9UMG3P8) POLYETHYLENE GLYCOL 7000 (UNII: Q0JET65GEL) PEG-9 POLYDIMETHYLSILOXYETHYL DIMETHICONE (UNII: TYP81E471F) PEG-10 DIMETHICONE (600 CST) (UNII: 8PR7V1SVM0) CYCLOMETHICONE 6 (UNII: XHK3U310BA) POTASSIUM METHOXYSALICYLATE (UNII: 5G3H7U4Y7F) TRIMETHYLSILOXYSILICATE (M/Q 0.6-0.8) (UNII: 5041RX63GN) PIPERIDINEPROPIONIC ACID (UNII: 6L69A7VPHO) .ALPHA.-TOCOPHEROL ACETATE, DL- (UNII: WR1WPI7EW8) DIMETHICONE/VINYL DIMETHICONE CROSSPOLYMER (SOFT PARTICLE) (UNII: 9E4CO0W6C5) 2-O-ETHYL ASCORBIC ACID (UNII: 801M14RK9K) POLY(METHYL METHACRYLATE; 450000 MW) (UNII: Z47NNT4J11) PRUNUS SPECIOSA LEAF (UNII: Q71D900FVU) ANGELICA ACUTILOBA ROOT (UNII: 3W51R3EK30) SODIUM ACETYLATED HYALURONATE (UNII: WN66R7GL93) GREEN TEA LEAF (UNII: W2ZU1RY8B0) DISTEARDIMONIUM HECTORITE (UNII: X687XDK09L) ISODODECANE (UNII: A8289P68Y2) ALUMINUM HYDROXIDE (UNII: 5QB0T2IUN0) EDETATE TRISODIUM (UNII: 420IP921MB) BUTYLENE GLYCOL (UNII: 3XUS85K0RA) SODIUM CITRATE, UNSPECIFIED FORM (UNII: 1Q73Q2JULR) BUTYLATED HYDROXYTOLUENE (UNII: 1P9D0Z171K) BARIUM SULFATE (UNII: 25BB7EKE2E) .ALPHA.-TOCOPHEROL (UNII: H4N855PNZ1) CITRIC ACID MONOHYDRATE (UNII: 2968PHW8QP) SODIUM METABISULFITE (UNII: 4VON5FNS3C) ALCOHOL (UNII: 3K9958V90M) POLYMETHYLSILSESQUIOXANE (4.5 MICRONS) (UNII: 59Z907ZB69) DIPROPYLENE GLYCOL (UNII: E107L85C40) ALUMINUM OXIDE (UNII: LMI26O6933) PHENOXYETHANOL (UNII: HIE492ZZ3T) TITANIUM DIOXIDE (UNII: 15FIX9V2JP) FERRIC OXIDE RED (UNII: 1K09F3G675) FERRIC OXIDE YELLOW (UNII: EX438O2MRT) FERROSOFERRIC OXIDE (UNII: XM0M87F357) MICA (UNII: V8A1AW0880) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:58411-339-50 1 in 1 CARTON 08/01/2017 1 30 mL in 1 JAR; Type 0: Not a Combination Product Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC MONOGRAPH DRUG M020 08/01/2017 Labeler - SHISEIDO AMERICAS CORPORATION (193691821) Establishment Name Address ID/FEI Business Operations Shiseido America Inc. 782677132 ANALYSIS(58411-329, 58411-330, 58411-331, 58411-332, 58411-333, 58411-334, 58411-335, 58411-336, 58411-337, 58411-338, 58411-339) , MANUFACTURE(58411-329, 58411-330, 58411-331, 58411-332, 58411-333, 58411-334, 58411-335, 58411-336, 58411-337, 58411-338, 58411-339)
